Showing 1 - 10 of 961
We study age-rating restrictions in the health insurance marketplaces introduced by the Affordable Care Act. Because most buyers are subsidized, although age-rating restrictions affect pre-subsidy premiums, participation is primarily driven by subsidy generosity rather than pricing decisions....
Persistent link: https://www.econbiz.de/10012952817
We examine how substance use disorder (SUD) treatment providers respond to private health insurance expansions induced by state equal coverage ('parity') laws for SUD treatment. We use data on the near universe of specialty SUD treatment providers in the United States between 1997 and 2010 in an...
Persistent link: https://www.econbiz.de/10011596165
Since the inception of Medicare Part D in 2006, mergers and acquisitions (M&A) and regulatory changes have led to increased concentration and reduced plan variety in the standalone prescription drug plan (PDP) portion of the market. We examine how this industry consolidation affects Medicare...
Persistent link: https://www.econbiz.de/10014512121
We examine how substance use disorder (SUD) treatment providers respond to private health insurance expansions induced by state equal coverage ('parity') laws for SUD treatment. We use data on the near universe of specialty SUD treatment providers in the United States between 1997 and 2010 in an...
Persistent link: https://www.econbiz.de/10012965014
Public health insurance is increasingly provided indirectly by private health insurers receiving government subsidies. Previous models find that these subsidies can cause insurers to distort benefits towards services that attract profitable individuals and conversely to provide less favorable...
Persistent link: https://www.econbiz.de/10014147274
New South Wales, Australia. Our estimates indicate that the subsidies expanded access to oral chemotherapy for newly …
Persistent link: https://www.econbiz.de/10014249952
Using SOEP panel data and difference-in-differences methods, this study is the first to empirically evaluate the effectiveness of four different health care cost containment measures within an integrated framework. The four measures investigated were introduced in Germany in 1997 to reduce moral...
Persistent link: https://www.econbiz.de/10011600994
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10010274736
Persistent link: https://www.econbiz.de/10011696717
Rwanda is among the few countries in Sub-Saharan Africa and the developing approaching universal health insurance coverage. To date, over 90 per cent of the population are enrolled in the Mutuelles de Santé - a system that started off from a number of stand-alone community based health...
Persistent link: https://www.econbiz.de/10010310738